Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | 23 974 | déclaré | 02 févr. 2024 | tx 520+500 326−369 216 |
| Zymeworks Inc. | 7 700 | déclaré | 12 janv. 2026 | tx 3+81 200 |
| CYTOKINETICS INC | 4 301 | déclaré | 27 mai 2026 | tx 5+50 903 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 27 mai 2026 | GRANT_AWARD | CYTOKINETICS INC | 2 851 | 0.00 USD | |
| 27 mai 2026 | GRANT_AWARD | CYTOKINETICS INC | 4 301 | 0.00 USD | deriv |
| 12 janv. 2026 | GRANT_AWARD | Zymeworks Inc. | 7 700 | 0.00 USD | deriv |
| 12 janv. 2026 | GRANT_AWARD | Zymeworks Inc. | 11 500 | 0.00 USD | deriv |
| 11 août 2025 | GRANT_AWARD | Zymeworks Inc. | 62 000 | 0.00 USD | deriv |
| 14 mai 2025 | GRANT_AWARD | CYTOKINETICS INC | 7 333 | 0.00 USD | |
| 14 mai 2025 | GRANT_AWARD | CYTOKINETICS INC | 10 880 | 0.00 USD | deriv |
| 10 févr. 2025 | GRANT_AWARD | CYTOKINETICS INC | 25 538 | 0.00 USD | deriv |
| 02 févr. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 400 | 378.98 USD | |
| 02 févr. 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 281 | 956.65 USD | |
| 02 févr. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 400 | 0.00 USD | deriv |
| 31 janv. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 400 | 378.98 USD | |
| 31 janv. 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 282 | 953.42 USD | |
| 31 janv. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 400 | 0.00 USD | deriv |
| 23 janv. 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 776 | 948.50 USD | |
| 24 janv. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 500 | 378.98 USD | |
| 24 janv. 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 352 | 951.26 USD | |
| 23 janv. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1 100 | 378.98 USD | |
| 24 janv. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 500 | 0.00 USD | deriv |
| 23 janv. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1 100 | 0.00 USD | deriv |
| 17 janv. 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 354 | 932.34 USD | |
| 17 janv. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 500 | 378.98 USD | |
| 17 janv. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 500 | 0.00 USD | deriv |
| 12 janv. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 800 | 378.98 USD | |
| 12 janv. 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 568 | 928.18 USD |